
Wugen
Wugen is now Allotera A new era of Allogeneic T-Cell Therapies Continue to Allotera If you have any questions please contacts us at info@alloteratx.com Countdown Timer
$35M Series B+ ·
Source: fundraisingfox.com
Funding history ↓Signals
Website registeredNov 22, 2005 (21 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $35M | — | fundraisingfox.com |
Timeline
- Website created
Companies like Wugen
EEyestem$6.4M Series A · Aug 2022
TTinkeso TherapeuticsOOblenio Bio$62M Series B+ · Jun 2026
KKopilot.IDSeed · Sep 2026
DDeepflareSeed · Jul 2022
AAbcuro$66M Series B+ · Aug 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/wugen (get a free API key).